Similarly, SQLE is upregulated in nasopharyngeal cancer (13), head and neck squamous cell carcinoma (24), leukemia (25), hepatocellular cancer (26–28), and squamous lung cancer (29, 30). Here, SQLE is linked to nasopharyngeal carcinoma.